相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crystal Structures of IL-2-inducible T cell Kinase Complexed with Inhibitors: Insights into Rational Drug Design and Activity Regulation
Alan K. Kutach et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity
Fatih M. Uckun et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis.
Michael E. Weinblatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Structural Insights for Design of Potent Spleen Tyrosine Kinase Inhibitors from Crystallographic Analysis of Three Inhibitor Complexes
Armando G. Villasenor et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Structural biology contributions to tyrosine kinase drug discovery
Sandra W. Cowan-Jacob et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
A novel Syk kinase inhibitor suitable for inhalation: R-343(?) - WO-2009031011
Peter Norman
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders
David M. Goldstein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Bruton's Tyrosine Kinase as a Drug Discovery Target
Zhengying Pan
DRUG NEWS & PERSPECTIVES (2008)
Classifying protein kinase structures guides use of ligand-selectivity profiles to predict inactive conformations: Structure of lck/imatinib complex
Marc D. Jacobs et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Activation mechanism and steady state kinetics of Bruton's tyrosine kinase
Marie Dinh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 map kinase
DM Goldstein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families
SL Guo et al.
INTERNATIONAL IMMUNOLOGY (2006)
Likelihood-enhanced fast translation functions
AJ McCoy et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Bruton's tyrosine kinase:: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling
JM Lindvall et al.
IMMUNOLOGICAL REVIEWS (2005)
The conformational plasticity of protein kinases
M Huse et al.
CELL (2002)
Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia
C Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
